Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG:1349)
3.080
+0.050 (1.65%)
Mar 6, 2026, 4:08 PM HKT
18.92% (1Y)
| Market Cap | 7.60B +14.6% |
| Revenue (ttm) | 763.16M -3.3% |
| Net Income | -175.20M |
| EPS | -0.17 |
| Shares Out | 1.04B |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 0.07 (2.21%) |
| Ex-Dividend Date | n/a |
| Volume | 997,000 |
| Average Volume | 2,012,070 |
| Open | 3.030 |
| Previous Close | 3.030 |
| Day's Range | 3.020 - 3.110 |
| 52-Week Range | 2.130 - 5.290 |
| Beta | 0.12 |
| RSI | 47.38 |
| Earnings Date | Mar 31, 2026 |